Flagship company teams up with Charles River for AI drug discovery
One of Flagship’s entities will be getting access to an AI drug discovery tool from contract developer and manufacturer Charles River Laboratories.
On Thursday, Charles River announced that Pioneering Medicines, a unit of Flagship Pioneering, is seeking its services. The deal will see Pioneering Medicines have access to Charles River’s and Valo Health’s AI drug discovery platform, Logica. Pioneering Medicines plans to use the platform across several targets to find and create small molecules that can be eventually turned into new therapies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.